Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
Colorcon
Harvard Business School
McKesson

Last Updated: August 15, 2022

AMZEEQ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Amzeeq, and when can generic versions of Amzeeq launch?

Amzeeq is a drug marketed by Journey and is included in one NDA. There are twelve patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-nine patent family members in ten countries.

The generic ingredient in AMZEEQ is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

Paragraph IV (Patent) Challenges for AMZEEQ
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AMZEEQ Topical Aerosol Foam minocycline hydrochloride 4% 212379 1 2021-05-11

US Patents and Regulatory Information for AMZEEQ

AMZEEQ is protected by twelve US patents.

Patents protecting AMZEEQ

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Compositions, gels and foams with rheology modulators and uses thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Compositions and methods for treating rosacea and acne
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Method for healing of an infected acne lesion without scarring
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS


Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Compositions and methods for treating rosacea and acne
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Topical tetracycline compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Journey AMZEEQ minocycline hydrochloride AEROSOL, FOAM;TOPICAL 212379-001 Oct 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for AMZEEQ

See the table below for patents covering AMZEEQ around the world.

Country Patent Number Title Estimated Expiration
Israel 218862 See Plans and Pricing
Israel 225239 See Plans and Pricing
China 102686205 Topical tetracycline compositions See Plans and Pricing
Brazil 112012007473 composições tópicas de tetraciclina e respectivo método de uso See Plans and Pricing
World Intellectual Property Organization (WIPO) 2011039638 See Plans and Pricing
Israel 218861 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
Dow
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.